Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study
Suresh S. Ramalingam(Emory University), Yi Cheng, C. Zhou(Tongji University), Y. Ohe, Fumio Imamura(Osaka International Cancer Institute), Byoung Chul Cho(Yonsei University), Meng‐Chih Lin(Chang Gung University), Margarita Majem(Hospital de Sant Pau), Riyaz Shah(Maidstone and Tunbridge Wells NHS Trust), Yuri Rukazenkov(AstraZeneca (United Kingdom)), A. Todd(AstraZeneca (United Kingdom)), Aleksandra Markovets(AstraZeneca (United States)), J. Carl Barrett(AstraZeneca (United States)), Juliann Chmielecki(AstraZeneca (United States)), Jhanelle E. Gray(Moffitt Cancer Center)
Cited by 353Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis